Pharmaceutical Companies Stand in the Way of Treatment Essay -- Drug I

Pharmaceutical Companies pedestal in the Way of Treatment nobbleThis casebook concentrates on the controvert effects that the pharmaceutical industrys trade and production policies lose on third world nations deplorable from disease epidemics. My position is that pharmaceutical companies be not concerned with the health benefits of their drugs, but rather with the market place that their drugs generate. I illustrate this notion by describing the trade policies that pharmaceutical companies turn and the pharmaceutical companies production policies which concentrate on producing life-style drugs rather than drugs that repossess knockout diseases. Multinational pharmaceutical giants argon occupied with producing drugs that yield the roughly profits rather than with producing drugs to cure life-threatening diseases. Though many great deal in third world countries keep from curable or treatable morbific diseases such as malaria and tuberculosis, many of them go without treatment because the vaccines that cure these diseases are either too expensive for them to generate or they are not produced in sufficient quantities. To illustrate the down-production of necessary life-sustaining drugs is the fact that surrounded by 1975 and 1999, 1,393 new drugs were marketed, out of which only 16 were for neglected diseases that accounted for over 10% of the diseases in the World (Mdecins Sans Frontireticuloendothelial system). The Mdecins Sans Frontires (also known as Doctors Without Borders or MSF) is a non-profit organization that has contributed much attend to and effort in alleviating populations pathetic from endemic diseases and neglect. Because it is a non-profit organization and its goals are purely objective and humanitarian, the Mdecins Sans Frontires org... ... Times. 16 November 2001. 28 January 2004. - Ford, Nathan. do drugs Development for Neglected Diseases A Deficient Market and Public wellness Policy. The Lancet. 35 9 (2002) 2188-94- Martorell, Jordi. Drugs companies putting profits onward millions of peoples lives. Youth for International Socialism. 26 shew 2001. - Silverside, Ann. No Turning tail on Cheap Drugs for Poor Nations. Canadian Medical Journal. 169 (2003) 1067.- Silverstein, Ken. Millions for Viagra, Pennies for the Poor. The Nation. 7 July 1999. 10 February 2004. - WTO Takes First Step. The Lancet. 362 (2003) 753 Pharmaceutical Companies Stand in the Way of Treatment Essay -- Drug IPharmaceutical Companies Stand in the Way of TreatmentAbstractThis casebook concentrates on the negative effects that the pharmaceutical industrys trade and production policies have on third world nations suffering from disease epidemics. My position is that pharmaceutical companies are not concerned with the health benefits of their drugs, but rather with the market that their drugs generate. I illustrate this notion by describing t he trade policies that pharmaceutical companies influence and the pharmaceutical companies production policies which concentrate on producing life-style drugs rather than drugs that cure life-threatening diseases. Multinational pharmaceutical giants are occupied with producing drugs that yield the most profits rather than with producing drugs to cure life-threatening diseases. Though many people in third world countries suffer from curable or treatable infectious diseases such as malaria and tuberculosis, many of them go without treatment because the vaccines that cure these diseases are either too expensive for them to afford or they are not produced in sufficient quantities. To illustrate the down-production of necessary life-sustaining drugs is the fact that between 1975 and 1999, 1,393 new drugs were marketed, out of which only 16 were for neglected diseases that accounted for over 10% of the diseases in the World (Mdecins Sans Frontires). The Mdecins Sans Frontires (also kn own as Doctors Without Borders or MSF) is a non-profit organization that has contributed much aid and effort in alleviating populations suffering from endemic diseases and neglect. Because it is a non-profit organization and its goals are purely objective and humanitarian, the Mdecins Sans Frontires org... ... Times. 16 November 2001. 28 January 2004. - Ford, Nathan. Drug Development for Neglected Diseases A Deficient Market and Public Health Policy. The Lancet. 359 (2002) 2188-94- Martorell, Jordi. Drugs companies putting profits before millions of peoples lives. Youth for International Socialism. 26 March 2001. - Silverside, Ann. No Turning Back on Cheap Drugs for Poor Nations. Canadian Medical Journal. 169 (2003) 1067.- Silverstein, Ken. Millions for Viagra, Pennies for the Poor. The Nation. 7 July 1999. 10 February 2004. - WTO Takes First Step. The Lancet. 362 (2003) 753